[go: up one dir, main page]

AR053977A1 - Composiciones farmaceuticas con enmascaramiento de sabor - Google Patents

Composiciones farmaceuticas con enmascaramiento de sabor

Info

Publication number
AR053977A1
AR053977A1 ARP050104258A ARP050104258A AR053977A1 AR 053977 A1 AR053977 A1 AR 053977A1 AR P050104258 A ARP050104258 A AR P050104258A AR P050104258 A ARP050104258 A AR P050104258A AR 053977 A1 AR053977 A1 AR 053977A1
Authority
AR
Argentina
Prior art keywords
suspension
ready
pharmaceutical compositions
active substance
flavor mask
Prior art date
Application number
ARP050104258A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33443791&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR053977(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of AR053977A1 publication Critical patent/AR053977A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Composicion farmacéutica para administracion oral para la preparacion de una suspension lista para uso que comprende partículas cubiertas comprendiendo una substancia activa que tiene un sabor desagradable y/o amargo, tal como claritromicina, y una base de suspension que comprende una substancia osmoticamente activa capaz de proporcionar una alta osmolaridad a la mezcla de la base de suspension con un medio de suspension acuoso en la suspension lista para uso. Dicha suspension lista para uso mantiene su buen sabor durante un período prolongado de tiempo a través d aquellas condiciones osmoticas definidas.
ARP050104258A 2004-10-12 2005-10-11 Composiciones farmaceuticas con enmascaramiento de sabor AR053977A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0422645A GB2419094A (en) 2004-10-12 2004-10-12 Pharmaceutical composition of unpleasnt tasing active substances

Publications (1)

Publication Number Publication Date
AR053977A1 true AR053977A1 (es) 2007-05-30

Family

ID=33443791

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104258A AR053977A1 (es) 2004-10-12 2005-10-11 Composiciones farmaceuticas con enmascaramiento de sabor

Country Status (14)

Country Link
US (1) US7767231B2 (es)
EP (1) EP1802275B1 (es)
JP (1) JP5134961B2 (es)
CN (1) CN101083977B (es)
AR (1) AR053977A1 (es)
AU (1) AU2005293800B2 (es)
BR (1) BRPI0517413A (es)
CA (1) CA2581493C (es)
ES (1) ES2514468T3 (es)
GB (1) GB2419094A (es)
RU (1) RU2399370C2 (es)
SI (1) SI1802275T1 (es)
WO (1) WO2006040112A2 (es)
ZA (1) ZA200702418B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132090B2 (ja) * 2006-06-16 2013-01-30 東和薬品株式会社 塩酸エピナスチンドライシロップ剤
US9040089B2 (en) * 2008-07-22 2015-05-26 Lupin Limited Oral compositions of clindamycin
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
EA022924B1 (ru) * 2009-04-03 2016-03-31 Ф.Хоффманн-Ля Рош Аг ТВЁРДАЯ ФОРМА {3-[5-(4-ХЛОРФЕНИЛ)-1Н-ПИРРОЛО[2,3-b]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ И ЕЁ ПРИМЕНЕНИЕ
CN101879141B (zh) * 2009-05-05 2013-07-17 烟台绿叶动物保健品有限公司 一种掩味替米考星胃溶颗粒制剂
US9962336B2 (en) * 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
EP3137060B2 (en) 2014-05-01 2023-12-20 Sun Pharmaceutical Industries Ltd Extended release suspension compositions
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
US20160317388A1 (en) * 2014-05-01 2016-11-03 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
CA2956902A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
WO2019136053A1 (en) * 2018-01-03 2019-07-11 Ferring B.V. Oral liquid pharmaceutical compositions of aminosalicylates
WO2020180690A1 (en) * 2019-03-01 2020-09-10 Avadel Legacy Pharmaceuticals, Llc Liquid pharmaceutical compositions with stable drug release profiles
CN115634203B (zh) * 2022-10-28 2024-06-25 南京海纳医药科技股份有限公司 一种含有依巴斯汀的干混悬剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4994260A (en) 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4808411A (en) 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
IL104093A (en) 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
JPH05255073A (ja) * 1992-03-12 1993-10-05 Taisho Pharmaceut Co Ltd 経口製剤およびその製造方法
WO1994005260A1 (en) * 1992-09-03 1994-03-17 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
AU3154895A (en) * 1994-08-01 1996-03-04 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
EP0943341A1 (en) 1998-02-18 1999-09-22 Oscar Gold Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides
IN191239B (es) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
ATE248588T1 (de) 1999-06-11 2003-09-15 Ranbaxy Lab Ltd Geschmacksmaskierte zubereitungen
CA2445606A1 (en) * 2001-05-11 2002-11-21 Pacific Pharmaceuticals Limited Taste masking pharmaceutical composition
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
AU2002302903B2 (en) * 2001-06-22 2007-05-17 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drug
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung

Also Published As

Publication number Publication date
EP1802275A2 (en) 2007-07-04
CN101083977B (zh) 2013-03-06
CN101083977A (zh) 2007-12-05
GB0422645D0 (en) 2004-11-10
RU2399370C2 (ru) 2010-09-20
RU2007117499A (ru) 2008-11-20
WO2006040112A2 (en) 2006-04-20
ZA200702418B (en) 2009-04-29
JP5134961B2 (ja) 2013-01-30
GB2419094A (en) 2006-04-19
JP2008515946A (ja) 2008-05-15
AU2005293800A1 (en) 2006-04-20
EP1802275B1 (en) 2014-07-23
CA2581493A1 (en) 2006-04-20
AU2005293800B2 (en) 2009-03-26
US20080008765A1 (en) 2008-01-10
BRPI0517413A (pt) 2008-10-07
ES2514468T3 (es) 2014-10-28
US7767231B2 (en) 2010-08-03
WO2006040112A3 (en) 2007-04-26
CA2581493C (en) 2013-02-19
SI1802275T1 (sl) 2014-11-28

Similar Documents

Publication Publication Date Title
AR053977A1 (es) Composiciones farmaceuticas con enmascaramiento de sabor
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
HN2008000964A (es) Enmascaramiento del sabor de polvos
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
ATE286057T1 (de) Pharmazeutische zubereitungen enthaltend clavulansäure
EA200602137A1 (ru) Гидрогелевые препараты интерферона
TW200716202A (en) Pediatric formulation of topiramate
ATE382356T1 (de) Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
ATE454136T1 (de) Therapeutische zusammensetzungen zur pulmonalen verabreichung
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
AR043418A1 (es) Formulaciones liquidas de las proteinas de union del factor necrosis del tumor
DE60316714D1 (de) Pharmazeutische formulierung enthaltend olanzapin
AR042598A1 (es) Composiciones de acetaminofeno
ITMI20032087A1 (it) Film autosupportanti per uso farmaceutico ed alimentare.
HRP20050787A2 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
EA200701228A1 (ru) Стабильные композиции фенофибрата с эфирами жирных кислот

Legal Events

Date Code Title Description
FB Suspension of granting procedure